Artrya Share Price and Company Fundamentals

0.040 (7.018%)
52 week
0.32 - 1.75

Last traded: Today at 3:14 AM

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Primary activitiesArtrya Limited is a medical technology company developing software which automates the analysis of heart computed tomography (CT) scans to assist in the diagnosis of Coronary Artery Disease.
Industry / SectorHealth Information Services / Healthcare
Mailing address1257 Hay Street West Perth WA 6005 Australia
Phone / Fax61 8 6478 7816 /


More: Artrya Dividend history, yield and payout ratio

Dividend yield


Dividend amount


Payout ratio


Artrya paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AYA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AYA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Artrya.

NameTitleAgeTotal Pay
Mr. John Windsor Barrington A.M., F.A.C.I.D., M.B.A.Co-founder, CEO, MD & Director
Mr. John Konstantopoulos B.E.Co-Founder, Exec. Director of Product & Director
Mr. Mark WainwrightChief Financial Officer
Dr. Julien FlackChief Technology Officer
Prof. Girish Dwivedi M.D.Chief Scientific Officer
Ms. Janice MarconChief People & Culture Officer
Dr. Jacob Agris M.D., Ph.D.Chief Medical Officer
Mr. Riaz KingstonHead of Bus. Devel.
Mr. Nathan BartropCompany Sec.
Dr. Jacque J. Sokolov B.A., M.D.Non-Exec. Director, Chair & Pres of Artrya USA Inc66

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Artrya is and its enterprise value is .

Companies similar to Artrya (AYA)

Artrya (ASX:AYA) Frequently Asked Questions

1. What is Artrya's Stock Symbol?

Artrya trades on ASX under the ticker symbol "AYA".

2. What is Artrya's stock price today?

One share of AYA stock can currently be purchased for approximately $0.61.

3. How can I contact Artrya?

Artrya's mailing address is 1257 Hay Street West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6478 7816.

4. What is Artrya's official website?

The official website of Artrya is

5. Which share registry manages Artrya's stock?